- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06930131
Effekt av anomia -rehabilitering kombinert med metakognitiv trening hos pasienter med kronisk vaskulær afasi (METALEX)
The postulate of this study is that rehabilitation combining linguistic and metacognitive training will result in a significant improvement in language performance correlated with changes in functional cerebral connectivity networks. In addition, it could potentiate the generalisation of effects to verbal and non-verbal communication skills, having a direct impact on patients' quality of life. This research is a prospective, randomized controlled, open-label, single-centre study. It is part of the management of patients with aphasia who have suffered a cerebral infarction and aims to evaluate the effect of combined language semantics/metacognition rehabilitation.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Vascular aphasia occurs after 20 to 25% of strokes and leads to anomia or word-finding difficulties in many patients. Speech therapy, which is the standard treatment, notably employs Semantic Feature Analysis (SFA). SFA aims to teach patients a strategy that helps activate semantic links strongly associated with the target word, thereby facilitating word retrieval.
Moreover, a growing number of studies suggest combining metacognitive strategy training with language rehabilitation in brain-injured patients, particularly in reading comprehension, communication skills, and anomia, could improve cognitive and language recovery outcomes. In rehabilitation, metacognitive strategy training can be used to enhance and/or compensate for cognitive function deficits. Patients are repeatedly exposed to discrepancies between the patients performance evaluations and expectations. Findings indicate improvements in trained tasks and transfer effects to similar tasks.
While studies have examined the effects of linguistic training on one hand and the impact of metacognitive abilities on the other, to the investigators knowledge, no study has assessed the effect of a combined linguistic and metacognitive training approach in post-stroke aphasic patients on behavioral and imaging variables. This study postulates that rehabilitation combining linguistic and metacognitive training will lead to a significant improvement in language performance, correlated with changes in functional brain connectivity networks. Furthermore, it may enhance the generalization of effects to both verbal and non-verbal communication skills, directly impacting patients' quality of life.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Lola DANET
- Telefonnummer: 05 61 77 76 86
- E-post: danet.l@chu-toulouse.fr
Studiesteder
-
-
-
Toulouse, Frankrike
- Rekruttering
- University Hospital of Toulouse
-
Ta kontakt med:
- Lola Danet, phD
- E-post: danet.l@chu-toulouse.fr
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- First cerebral infarction
- Chronic phase (> 3 months)
- Patient affiliated to a health insurance scheme
- Usual french language
- Severity score measures using the Boston Diagnostic Aphasia Examination battery scale corresponding to the mild or moderate level (score greater than or equal to 2)
Exclusion Criteria:
- Contraindication to undergoing brain MRI
- Cognitive impairment pre-existing stroke (CQI code > 3.4) (Law et al., 1995)
- Chronic alcohol or drug abuse
- Unstabilised psychiatric illness
- Uncorrected sensory deficits
- Diagnosed as having a progressive general pathology
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: 6 uker Fase A (baseline)
|
Semantic rehabilitation, consisting of validated lexico-phonological training exercises |
|
Annen: 7 uker Fase A (baseline)
|
Semantic rehabilitation, consisting of validated lexico-phonological training exercises |
|
Annen: 8 uker Fase A (baseline)
|
Semantic rehabilitation, consisting of validated lexico-phonological training exercises |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Performance at the "TD-264" untrained naming items task
Tidsramme: Baseline, Up to 8 weeks, Up to 13 weeks
|
The "TD-264 untrained naming items task" is a naming task of 264 images. Words corresponding to the images correctly named are "set success" and words wrongly named are "set treatment". The score at the task is composite :
Scores are all from 0 to 264. 0 being the worst performance possible and 264 being the best performance possible. |
Baseline, Up to 8 weeks, Up to 13 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Reorganization of patients' functional connectivity maps compared to healthy volunteers
Tidsramme: Up to 8 weeks ; Up to 13 weeks
|
Reorganization of the functional connectivity of patients measured by the difference between the activation maps at the end of phase A and at the end of phase B, thanks to the acquisition of resting functional MRI sequences on the MRI dedicated to research (acquisition of resting-state MRI sequences) |
Up to 8 weeks ; Up to 13 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Organisering av lungebetennelse
- Nevrologiske manifestasjoner
- Cerebrovaskulære lidelser
- Hjernesykdommer
- Sykdommer i sentralnervesystemet
- Sykdommer i nervesystemet
- Vaskulære sykdommer
- Kardiovaskulære sykdommer
- Sykdommer i immunsystemet
- Sykdommer i luftveiene
- Nevroatferdsmanifestasjoner
- Lungesykdommer
- Bronkiale sykdommer
- Lungesykdommer, obstruktiv
- Kommunikasjonsforstyrrelser
- Bronchiolitis Obliterans
- Bronkiolitt
- Bronkitt
- Språkforstyrrelser
- Taleforstyrrelser
- Graft vs vertssykdom
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Bronchiolitis Obliterans syndrom
- Slag
- Afasi
Andre studie-ID-numre
- RC31/22/0503
- 2024-A01842-45 (Annen identifikator: ANSM)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .